Detalles de la búsqueda
1.
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide.
Cancer
; 124(7): 1428-1437, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360162
2.
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).
Bone Marrow Transplant
; 58(10): 1084-1088, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37420011
3.
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther
; 28(10): 710.e1-710.e10, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830930
4.
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant
; 57(4): 562-571, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35079140
5.
Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT.
Bone Marrow Transplant
; 56(8): 1842-1849, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33674790
Resultados
1 -
5
de 5
1
Próxima >
>>